Conduit Pharmaceuticals所有資訊

4：持股變動聲明-董事 Farley Chele Chiavacci

06/11 17:58 (美東)

4：持股變動聲明-高管 Bligh James

06/11 17:58 (美東)

8-K：重大事件

05/31 17:05 (美東)

424B3：募資說明書

05/16 16:35 (美東)

4：持股變動聲明-高管 Sragovicz Adam

05/15 22:26 (美東)

4：持股變動聲明-董事 McNealey Jennifer Isacoff

05/15 16:55 (美東)

10-Q：季度報表

05/14 16:10 (美東)

EFFECT：其他

05/03 06:06 (美東)

POS AM：修改註冊聲明表

05/02 14:16 (美東)

4：持股變動聲明-董事 Farley Chele Chiavacci

04/24 17:06 (美東)

4：持股變動聲明-董事 Lewis-Hall Freda C

04/24 17:06 (美東)

4：持股變動聲明-高管 Tapolczay David

04/24 17:05 (美東)

10-K：年度報表

04/16 17:31 (美東)

8-K：重大事件

04/16 17:31 (美東)

Conduit Pharmaceuticals | NT 10-K：其他

04/01 16:58 (美東)

Conduit Pharmaceuticals | SC 13G/A：超過5%持股股東披露文件(修正)-Polar Asset Management Partners Inc.(1.3%)

02/12 12:56 (美東)

Conduit Pharmaceuticals | SC 13G/A：超過5%持股股東披露文件(修正)-Saba Capital Management, L.P.(0%),Boaz R. Weinstein(0%)等

02/08 13:21 (美東)

Conduit Pharmaceuticals | SC 13G/A：超過5%持股股東披露文件(修正)-Hudson Bay Capital Management LP(0.10%),Sander Gerber(0.10%)

02/02 16:33 (美東)

Conduit Pharmaceuticals | S-8：員工福利計劃證券登記

01/10 00:00 (美東)

Conduit Pharmaceuticals | 424B3：募資說明書

2023/12/18 16:14 (美東)